Search for: "BIOTECH, INC."
Results 1 - 20
of 1,245
Sorted by Relevance
|
Sort by Date
23 Feb 2011, 9:59 pm
By Donald Zuhn -- Today, in Centocor Ortho Biotech, Inc. v. [read post]
10 Jul 2014, 9:59 pm
("AbbVie") and Janssen Biotech, Inc. and Centocor Biologics, LLC ("Centocor"). [read post]
29 Jan 2018, 9:59 pm
Janssen Biotech, Inc. and New York University ("Janssen"), co-assignees of the '471 patent, argued on appeal that obviousness-type double patenting was not applicable because the safe-harbor provision of 35 U.S.C. [read post]
15 May 2017, 9:50 pm
Patent and Trademark Office has now filed its response brief in In re: Janssen Biotech, Inc., New York University, No. 2017-1257 (Fed. [read post]
15 Mar 2007, 10:08 am
Revenues for 2006 were $2.0 billion and the company is headquartered in East Hills, New York.Bioquate, Inc., on the other hand, is a Clearwater, Florida, based biotech manufacturer providing the biotech industry with a narrowly focused line of disposable devices products. [read post]
19 Mar 2007, 9:49 pm
By Donald Zuhn --- Windhover Information Inc. will be holding the 14th Annual Euro-Biotech Forum 2007 on June 26-28, 2007 in Paris, France. [read post]
14 Mar 2011, 8:24 pm
In August 2010, it sued defendant Marina Biotech, a Seattle- and Boston-based biotech company, five days after defendant changed its name from MDRNA, Inc. [read post]
20 Feb 2009, 9:59 pm
By Jason Derry* and Donald Zuhn --GPC Biotech and Agennix to Merge GPC Biotech AG and Agennix Inc. have announced a plan to merge. [read post]
16 Jun 2020, 5:00 pm
For this episode, David and Kevin discuss his new book, Massachusetts Biotech Boom, about looking inside the Massachusetts Biotech Boom and why he wrote this book. [read post]
16 Apr 2013, 2:58 pm
Supreme Court's Myriad Genetics Inc. case. [read post]
27 May 2009, 9:59 pm
By Donald Zuhn -- In a Breakout Session entitled "The Narrowing Scope of Biotech Patent Claims: What Does It Mean for the Industry? [read post]
26 Nov 2019, 8:50 am
The Securities and Exchange Commission today charged Georgia-based biotech company MiMedx Group Inc. and three former top executives with defrauding investors by misstating the company’s revenue and attempting to cover up their misconduct. [read post]
28 Aug 2020, 10:26 am
PROGENITY, INC. [read post]
2 Jan 2024, 8:45 pm
SweeGen, Inc. [read post]
8 Aug 2018, 9:08 am
Fortress Biotech Inc. [read post]
7 Oct 2013, 7:50 pm
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar on "Written Description of Biotech Inventions: Insight from the USPTO" on October 10, 2013 beginning at 2:00 pm (ET). [read post]
24 Mar 2014, 9:13 pm
The cases were IPR2012-00006, IPR2012-00007, and IPR2013-00011, and the parties were Illumina, Inc. [read post]
20 Dec 2008, 5:32 am
With both houses of Congress expected to renew their efforts to pass patent reform and follow-on biologics bills in 2009, we provide the following update on third quarter biotech/pharma lobbying activities: • Amgen Inc. spent $2.4 million on third... [read post]
7 Jun 2008, 3:34 am
Included on our list were Cephalon, Inc., which spent $512,000, Abbott Laboratories, which spent $880,000, and Amgen Inc., which spent $2.5 million. [read post]
28 Jul 2009, 1:26 pm
Centocor Ortho Biotech Inc. created when Ortho Biotech Inc. merged into Centocor, Inc., and Centocor, Inc. was renamed [...] [read post]
